These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16263833)

  • 1. Noonan syndrome: relationships between genotype, growth, and growth factors.
    Limal JM; Parfait B; Cabrol S; Bonnet D; Leheup B; Lyonnet S; Vidaud M; Le Bouc Y
    J Clin Endocrinol Metab; 2006 Jan; 91(1):300-6. PubMed ID: 16263833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
    Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent growth response to growth hormone therapy in a child with PTPN11-negative Noonan syndrome and features of growth hormone resistance.
    Walton-Betancourth S; Martinelli CE; Thalange NK; Dyke MP; Acerini CL; White S; Camacho-Hübner C; Savage MO
    J Endocrinol Invest; 2007 May; 30(5):439-41. PubMed ID: 17598979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
    Domené HM; Scaglia PA; Lteif A; Mahmud FH; Kirmani S; Frystyk J; Bedecarrás P; Gutiérrez M; Jasper HG
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4444-50. PubMed ID: 17726072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure.
    Hwa V; Haeusler G; Pratt KL; Little BM; Frisch H; Koller D; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 May; 91(5):1826-31. PubMed ID: 16507628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia.
    Heath KE; Argente J; Barrios V; Pozo J; Díaz-González F; Martos-Moreno GA; Caimari M; Gracia R; Campos-Barros A
    J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].
    Ferreira LV; Souza SA; Montenegro LR; Arnhold IJ; Pasqualini T; Heinrich JJ; Keselman AC; Mendonça BB; Jorge AA
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):450-6. PubMed ID: 17546245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
    Noordam C; Peer PG; Francois I; De Schepper J; van den Burgt I; Otten BJ
    Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children.
    Garrone S; Radetti G; Sidoti M; Bozzola M; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5455-60. PubMed ID: 12466336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration.
    Binder G; Seidel AK; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Eggermann T; Ranke MB
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1402-7. PubMed ID: 18230663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
    Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
    Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.